Maria Rita Castellani

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau‐Couanet et al. · The Lancet Oncology · 2018 · 379 citations

Interleukin 2, Autoimmune Disease, Anti-gd2 Antibody Ch14.18/cho +7

131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging

Emilio Bombardieri, Francesco Giammarile, Cumali Aktolun et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 295 citations

Oncologic Imaging, Medical Imaging, Procedure Guidelines +5

Guidelines on nuclear medicine imaging in neuroblastoma

Zvi Bar‐Sever, Lorenzo Biassoni, Barry L. Shulkin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 154 citations

Nuclear Imaging, Engineering, Medical Imaging +7

Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)

Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau‐Couanet et al. · Cancers · 2020 · 139 citations · Full text

Congenital renal damage associated with primary vesicoureteral reflux detected prenatally in male infants

Giuseppina Marra, G Barbieri, C. A. Dell’Agnola et al. · The Journal of Pediatrics · 1994 · 138 citations

Urology, Neonatology, Medicine +10